Zevra Therapeutics
ZVRA
#7052
Rank
C$0.56 B
Marketcap
$10.48
Share price
4.55%
Change (1 day)
56.05%
Change (1 year)

Zevra Therapeutics (ZVRA) - Cash on Hand

Cash on Hand as of December 2024 : C$98.92 Million

According to Zevra Therapeutics's latest financial reports the company has C$98.92 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Zevra Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$99.72 M
2022-12-31C$0.11 B-21.48%
2021-12-31C$0.14 B2565.33%
2020-12-31C$5.37 M27.85%
2019-12-31C$4.2 M-85.77%
2018-12-31C$29.51 M-44.4%
2017-12-31C$53.09 M-41.7%
2016-12-31C$91.06 M27.92%
2015-12-31C$71.19 M498.21%
2014-12-31C$11.9 M467.89%
2013-12-31C$2.09 M